Neonicotinoids are a class of pesticides widely used in different phases of agricultural crops. Similar to other classes of pesticides, they can damage human and environmental health if overused, and can be resistent to degradation. This is especially relevant to insect health, pollination, and aquatic biodiversity. Nevertheless, application of pesticides is still crucial for food production and pest control, and should therefore be carefully monitored by the government to control or reduce neonicotinoid contamination reaching human and animal feed. Aware of this problem, studies have been carried out to reduce or eliminate neonicotinoid contamination from the environment. One example of a green protocol is bioremediation. This review discusses the most recent microbial biodegradation and bioremediation processes for neonicotinoids, which employ isolated microorganisms (bacteria and fungi), consortiums of microorganisms, and different types of soils, biobeds, and biomixtures.In this study, we investigated the efficiency of photocatalytic degradation and chemical oxygen demand (COD) reduction from woodchips industry wastewater using α-Fe2O3@TiO2@SO3H. A magnetic α-Fe2O3@TiO2@SO3H was prepared as a heterogeneous photo-Fenton catalyst. The Fourier transform infrared (FT-IR), X-ray diffraction (XRD), Brunauer-Emmett-Teller (BET), scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy-dispersive X-ray (EDX), and elemental mapping (MAP) analyses were performed to determine the structure and morphology of synthesized photocatalysts. The response surface methodology (RSM) was used to optimize the photo-Fenton process based on a Box-Behnken design (BBD). The parameters such as catalyst dosage, H2O2 dosage, pH, and contact time on photocatalytic degradation and the reduction of COD were studied. The maximum photocatalytic degradation of 93.75% and COD reduction of 86.54% were achieved at a dosage of the catalyst of 1 g L-1, H2O2 dosage of 40 mg L-1, and a pH of 3.5 at 45 min. The kinetics of the photo-Fenton process was studied for the woodchips wastewater treatment under optimum conditions. The pseudo-second-order kinetic model for photocatalytic degradation and COD reduction was obtained. The results indicated that a α-Fe2O3@TiO2@SO3H could be used as an effective heterogeneous photocatalyst for the treatment of woodchips industry wastewater. Preparation and application of α-Fe2O3@TiO2@SO3H for photocatalytic degradation and COD reduction of woodchips industry wastewater. The recent introduction of edible insects in Western countries has raised concerns about their safety in terms of allergenic reactions. The characterization of insect allergens, the sensitization and cross-reactivity mechanisms, and the effects of food processing represent crucial information for risk assessment. Allergic reactions to different insects and cross-reactivity with crustacean and inhalant allergens have been described, with the identification of new IgE-binding proteins besides well-known pan-allergens. Depending on the route of sensitization, different potential allergens seem to be involved. Food processing may affect the solubility and the immunoreactivity of insect allergens, with results depending on species and type of proteins. https://www.selleckchem.com/products/srt2104-gsk2245840.html Chemical/enzymatic hydrolysis, in some cases, abolishes immunoreactivity. More studies based on subjects with a confirmed insect allergy are necessary to identify major and minor allergens and the role of the route of sensitization. The effects of processing need to be further investigated to assess the risk associated with the ingestion of insect-containing food products. Allergic reactions to different insects and cross-reactivity with crustacean and inhalant allergens have been described, with the identification of new IgE-binding proteins besides well-known pan-allergens. Depending on the route of sensitization, different potential allergens seem to be involved. Food processing may affect the solubility and the immunoreactivity of insect allergens, with results depending on species and type of proteins. Chemical/enzymatic hydrolysis, in some cases, abolishes immunoreactivity. More studies based on subjects with a confirmed insect allergy are necessary to identify major and minor allergens and the role of the route of sensitization. The effects of processing need to be further investigated to assess the risk associated with the ingestion of insect-containing food products. To describe symptoms and side effects experienced by patients with advanced non-small cell lung cancer (NSCLC), assess how patients allocate sensations (i.e. symptoms or side effects) to either the disease or its treatment, and evaluate how patients balance side effects with treatment benefits. Qualitative sub-studies were conducted as part of two clinical trials in patients treated for advanced NSCLC (AURA [NCT01802632]; ARCTIC [NCT02352948]). Interviews were conducted with 23 patients and 19 patients in the AURA and ARCTIC sub-studies, respectively. The most commonly experienced symptoms/side effects were respiratory (81% of patients), digestive (76%), pain and discomfort (76%), energy-related (71%), and sensory (62%). Patients identified a sensation as a treatment side effect if they had not experienced it before, if there was a temporal link between the sensation and receipt of treatment, and/or if their doctors consistently told or asked them about it in relation to side effects. Themes that emerged when patients talked about their cancer treatment and its side effects related to the serious nature of their advanced disease and their treatment expectations. Patients focused on treatment benefits, wanting a better quality of life, being hopeful, not really having a choice, and not thinking about side effects. In these two qualitative sub-studies, patients with advanced NSCLC valued the benefits of their treatment regardless of side effects that they experienced. Patients weighed their options against the seriousness of their disease and expressed their willingness to tolerate their side effects in return for receiving continued treatment benefits. In these two qualitative sub-studies, patients with advanced NSCLC valued the benefits of their treatment regardless of side effects that they experienced. Patients weighed their options against the seriousness of their disease and expressed their willingness to tolerate their side effects in return for receiving continued treatment benefits.